{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:07:03Z","timestamp":1784552823236,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.transproceed.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:45:05Z","timestamp":1781815505000},"page":"1014-1021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Appropriate Risk Classification and Low-Dose Rituximab May Help Prevent Acute Rejection in ABO-Compatible Living Kidney Transplantation"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4663-2972","authenticated-orcid":false,"given":"Miruzato","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiho","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2026.06.010_bib0001","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10157-016-1321-5","article-title":"Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation","volume":"21","author":"Takahashi","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0002","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes: a meta-analysis","volume":"13","author":"de Weerd","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0003","article-title":"Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: a network meta-analysis","volume":"100","author":"Lee","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0004","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.transproceed.2014.12.033","article-title":"Evaluation of rituximab dosage for ABO-incompatible living-donor kidney transplantation","volume":"47","author":"Nakao","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14915","article-title":"Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A\/B antibody titers: a single-center retrospective cohort study","volume":"37","author":"Okada","year":"2023","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.trre.2017.01.002","article-title":"A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection","volume":"31","author":"Macklin","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0007","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224203","article-title":"Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients","volume":"14","author":"Tomita","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0009","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0010","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/biomedicines10071506","article-title":"Non-HLA antibodies in kidney transplantation: immunity and genetic insights","volume":"10","author":"Sorohan","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2024.102054","article-title":"Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant","volume":"84","author":"Kitpermkiat","year":"2024","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0012","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/TP.0b013e31827be3c1","article-title":"Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA","volume":"95","author":"Zachary","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2026.06.010_bib0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ki.2014.261","article-title":"A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation","volume":"87","author":"Jackson","year":"2015","journal-title":"Kidney Int"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526003027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526003027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:55:29Z","timestamp":1784552129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526003027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0041134526003027"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.06.010","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate Risk Classification and Low-Dose Rituximab May Help Prevent Acute Rejection in ABO-Compatible Living Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}